Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 168 entries
Sorted by: Best Match Show Resources per page
Is whole gland salvage cryotherapy effective as palliative treatment of haematuria in patients with locally advanced prostate cancer? Results of a preliminary case series.

Therapeutic advances in urology

Magno C, Mucciardi G, Galì A, Pappalardo R, Lembo F, Anastasi G, Butticè S, Ascenti G, Lugnani F.
PMID: 26425138
Ther Adv Urol. 2015 Oct;7(5):235-40. doi: 10.1177/1756287215585451.

OBJECTIVES: Locally advanced prostate cancer may cause several complications such as haematuria, bladder outlet obstruction, and renal failure due to the ureteral obstruction. Various treatments have been suggested, including radiotherapy, antifibrinolytics, bladder irrigation with alum solution, transurethral surgery and...

Cite
Magno C, Mucciardi G, Galì A, et al. Is whole gland salvage cryotherapy effective as palliative treatment of haematuria in patients with locally advanced prostate cancer? Results of a preliminary case series. Ther Adv Urol. 2015;7(5):235-40doi: 10.1177/1756287215585451.
Magno, C., Mucciardi, G., Galì, A., Pappalardo, R., Lembo, F., Anastasi, G., Butticè, S., Ascenti, G., & Lugnani, F. (2015). Is whole gland salvage cryotherapy effective as palliative treatment of haematuria in patients with locally advanced prostate cancer? Results of a preliminary case series. Therapeutic advances in urology, 7(5), 235-40. https://doi.org/10.1177/1756287215585451
Magno, Carlo, et al. "Is whole gland salvage cryotherapy effective as palliative treatment of haematuria in patients with locally advanced prostate cancer? Results of a preliminary case series." Therapeutic advances in urology vol. 7,5 (2015): 235-40. doi: https://doi.org/10.1177/1756287215585451
Magno C, Mucciardi G, Galì A, Pappalardo R, Lembo F, Anastasi G, Butticè S, Ascenti G, Lugnani F. Is whole gland salvage cryotherapy effective as palliative treatment of haematuria in patients with locally advanced prostate cancer? Results of a preliminary case series. Ther Adv Urol. 2015 Oct;7(5):235-40. doi: 10.1177/1756287215585451. PMID: 26425138; PMCID: PMC4549698.
Copy Download .nbib Format: NLM
Group of signs: a new method to evaluate glycemic variability.

Journal of diabetes science and technology

Zaccardi F, Stefano PD, Busetto E, Federici MO, Manto A, Infusino F, Lanza GA, Pitocco D, Ghirlanda G.
PMID: 19885294
J Diabetes Sci Technol. 2008 Nov;2(6):1061-5. doi: 10.1177/193229680800200614.

BACKGROUND: Glycemic variability is an important parameter used to resolve potential clinical problems in diabetic patients. It is known that glycemic variability generates oxidative stress and potentially contributes to the development of macro- and microvascular complications in diabetes. By...

Cite
Zaccardi F, Stefano PD, Busetto E, et al. Group of signs: a new method to evaluate glycemic variability. J Diabetes Sci Technol. 2008;2(6):1061-5doi: 10.1177/193229680800200614.
Zaccardi, F., Stefano, P. D., Busetto, E., Federici, M. O., Manto, A., Infusino, F., Lanza, G. A., Pitocco, D., & Ghirlanda, G. (2008). Group of signs: a new method to evaluate glycemic variability. Journal of diabetes science and technology, 2(6), 1061-5. https://doi.org/10.1177/193229680800200614
Zaccardi, Francesco, et al. "Group of signs: a new method to evaluate glycemic variability." Journal of diabetes science and technology vol. 2,6 (2008): 1061-5. doi: https://doi.org/10.1177/193229680800200614
Zaccardi F, Stefano PD, Busetto E, Federici MO, Manto A, Infusino F, Lanza GA, Pitocco D, Ghirlanda G. Group of signs: a new method to evaluate glycemic variability. J Diabetes Sci Technol. 2008 Nov;2(6):1061-5. doi: 10.1177/193229680800200614. PMID: 19885294; PMCID: PMC2769822.
Copy Download .nbib Format: NLM
Issues in the management of acute agitation: how much current guidelines consider safety?.

Frontiers in psychiatry

Pacciardi B, Mauri M, Cargioli C, Belli S, Cotugno B, Di Paolo L, Pini S.
PMID: 23675355
Front Psychiatry. 2013 May 07;4:26. doi: 10.3389/fpsyt.2013.00026. eCollection 2013.

Agitated behavior constitutes up to 10% of emergency psychiatric interventions. Pharmacological tranquilization is often used as a valid treatment for agitation but a strong evidence base does not underpin it. Available literature shows different recommendations, supported by research data,...

Cite
Pacciardi B, Mauri M, Cargioli C, et al. Issues in the management of acute agitation: how much current guidelines consider safety?. Front Psychiatry. 2013;4:26doi: 10.3389/fpsyt.2013.00026.
Pacciardi, B., Mauri, M., Cargioli, C., Belli, S., Cotugno, B., Di Paolo, L., & Pini, S. (2013). Issues in the management of acute agitation: how much current guidelines consider safety?. Frontiers in psychiatry, 426. https://doi.org/10.3389/fpsyt.2013.00026
Pacciardi, Bruno, et al. "Issues in the management of acute agitation: how much current guidelines consider safety?." Frontiers in psychiatry vol. 4 (2013): 26. doi: https://doi.org/10.3389/fpsyt.2013.00026
Pacciardi B, Mauri M, Cargioli C, Belli S, Cotugno B, Di Paolo L, Pini S. Issues in the management of acute agitation: how much current guidelines consider safety?. Front Psychiatry. 2013 May 07;4:26. doi: 10.3389/fpsyt.2013.00026. eCollection 2013. PMID: 23675355; PMCID: PMC3646256.
Copy Download .nbib Format: NLM
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation.

Oncotarget

Costa F, Toscani D, Chillemi A, Quarona V, Bolzoni M, Marchica V, Vescovini R, Mancini C, Martella E, Campanini N, Schifano C, Bonomini S, Accardi F, Horenstein AL, Aversa F, Malavasi F, Giuliani N.
PMID: 28915615
Oncotarget. 2017 May 16;8(34):56598-56611. doi: 10.18632/oncotarget.17896. eCollection 2017 Aug 22.

It is known that multiple myeloma (MM) cells express CD38 and that a recently developed human anti-CD38 monoclonal antibody Daratumumab mediates myeloma killing. However, the expression of CD38 and other functionally related ectoenzymes within the MM bone niche and...

Cite
Costa F, Toscani D, Chillemi A, et al. Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation. Oncotarget. 2017;8(34):56598-56611doi: 10.18632/oncotarget.17896.
Costa, F., Toscani, D., Chillemi, A., Quarona, V., Bolzoni, M., Marchica, V., Vescovini, R., Mancini, C., Martella, E., Campanini, N., Schifano, C., Bonomini, S., Accardi, F., Horenstein, A. L., Aversa, F., Malavasi, F., & Giuliani, N. (2017). Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation. Oncotarget, 8(34), 56598-56611. https://doi.org/10.18632/oncotarget.17896
Costa, Federica, et al. "Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation." Oncotarget vol. 8,34 (2017): 56598-56611. doi: https://doi.org/10.18632/oncotarget.17896
Costa F, Toscani D, Chillemi A, Quarona V, Bolzoni M, Marchica V, Vescovini R, Mancini C, Martella E, Campanini N, Schifano C, Bonomini S, Accardi F, Horenstein AL, Aversa F, Malavasi F, Giuliani N. Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation. Oncotarget. 2017 May 16;8(34):56598-56611. doi: 10.18632/oncotarget.17896. eCollection 2017 Aug 22. PMID: 28915615; PMCID: PMC5593586.
Copy Download .nbib Format: NLM
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.

Cancers

Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, Mancini C, Martella E, Ribatti D, Vacca A, Pistoia V, Giuliani N.
PMID: 30845779
Cancers (Basel). 2019 Mar 06;11(3). doi: 10.3390/cancers11030321.

C-X3-C motif chemokine ligand 1 (CX3CL1)/fractalkine is a chemokine released after cleavage by two metalloproteases, ADAM metallopeptidase domain 10 (ADAM10) and ADAM metallopeptidase domain 17 (ADAM17), involved in inflammation and angiogenesis in the cancer microenvironment. The role of the...

Cite
Marchica V, Toscani D, Corcione A, et al. Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers (Basel). 2019;11(3)doi: 10.3390/cancers11030321.
Marchica, V., Toscani, D., Corcione, A., Bolzoni, M., Storti, P., Vescovini, R., Ferretti, E., Dalla Palma, B., Vicario, E., Accardi, F., Mancini, C., Martella, E., Ribatti, D., Vacca, A., Pistoia, V., & Giuliani, N. (2019). Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers, 11(3), . https://doi.org/10.3390/cancers11030321
Marchica, Valentina, et al. "Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients." Cancers vol. 11,3 (2019). doi: https://doi.org/10.3390/cancers11030321
Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, Mancini C, Martella E, Ribatti D, Vacca A, Pistoia V, Giuliani N. Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers (Basel). 2019 Mar 06;11(3). doi: 10.3390/cancers11030321. PMID: 30845779; PMCID: PMC6469019.
Copy Download .nbib Format: NLM
Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.

Frontiers in immunology

Cifaldi C, Brigida I, Barzaghi F, Zoccolillo M, Ferradini V, Petricone D, Cicalese MP, Lazarevic D, Cittaro D, Omrani M, Attardi E, Conti F, Scarselli A, Chiriaco M, Di Cesare S, Licciardi F, Davide M, Ferrua F, Canessa C, Pignata C, Giliani S, Ferrari S, Fousteri G, Barera G, Merli P, Palma P, Cesaro S, Gattorno M, Trizzino A, Moschese V, Chini L, Villa A, Azzari C, Finocchi A, Locatelli F, Rossi P, Sangiuolo F, Aiuti A, Cancrini C, Di Matteo G.
PMID: 31214169
Front Immunol. 2019 May 31;10:1184. doi: 10.3389/fimmu.2019.01184. eCollection 2019.

[This corrects the article DOI: 10.3389/fimmu.2019.00316.].

Cite
Cifaldi C, Brigida I, Barzaghi F, et al. Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019;10:1184doi: 10.3389/fimmu.2019.01184.
Cifaldi, C., Brigida, I., Barzaghi, F., Zoccolillo, M., Ferradini, V., Petricone, D., Cicalese, M. P., Lazarevic, D., Cittaro, D., Omrani, M., Attardi, E., Conti, F., Scarselli, A., Chiriaco, M., Di Cesare, S., Licciardi, F., Davide, M., Ferrua, F., Canessa, C., Pignata, C., Giliani, S., Ferrari, S., Fousteri, G., Barera, G., Merli, P., Palma, P., Cesaro, S., Gattorno, M., Trizzino, A., Moschese, V., Chini, L., Villa, A., Azzari, C., Finocchi, A., Locatelli, F., Rossi, P., Sangiuolo, F., Aiuti, A., Cancrini, C., & Di Matteo, G. (2019). Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Frontiers in immunology, 101184. https://doi.org/10.3389/fimmu.2019.01184
Cifaldi, Cristina, et al. "Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies." Frontiers in immunology vol. 10 (2019): 1184. doi: https://doi.org/10.3389/fimmu.2019.01184
Cifaldi C, Brigida I, Barzaghi F, Zoccolillo M, Ferradini V, Petricone D, Cicalese MP, Lazarevic D, Cittaro D, Omrani M, Attardi E, Conti F, Scarselli A, Chiriaco M, Di Cesare S, Licciardi F, Davide M, Ferrua F, Canessa C, Pignata C, Giliani S, Ferrari S, Fousteri G, Barera G, Merli P, Palma P, Cesaro S, Gattorno M, Trizzino A, Moschese V, Chini L, Villa A, Azzari C, Finocchi A, Locatelli F, Rossi P, Sangiuolo F, Aiuti A, Cancrini C, Di Matteo G. Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 May 31;10:1184. doi: 10.3389/fimmu.2019.01184. eCollection 2019. PMID: 31214169; PMCID: PMC6554535.
Copy Download .nbib Format: NLM
Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: A UK Biobank study.

European journal of preventive cardiology

Zaccardi F, Franks PW, Dudbridge F, Davies MJ, Khunti K, Yates T.
PMID: 34247229
Eur J Prev Cardiol. 2021 Jul 10;28(7):704-712. doi: 10.1177/2047487319885041.

AIMS: Brisk walking and a greater muscle strength have been associated with a longer life; whether these associations are influenced by other lifestyle behaviours, however, is less well known.METHODS: Information on usual walking pace (self-defined as slow, steady/average, or...

Cite
Zaccardi F, Franks PW, Dudbridge F, et al. Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: A UK Biobank study. Eur J Prev Cardiol. 2021;28(7):704-712doi: 10.1177/2047487319885041.
Zaccardi, F., Franks, P. W., Dudbridge, F., Davies, M. J., Khunti, K., & Yates, T. (2021). Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: A UK Biobank study. European journal of preventive cardiology, 28(7), 704-712. https://doi.org/10.1177/2047487319885041
Zaccardi, Francesco, et al. "Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: A UK Biobank study." European journal of preventive cardiology vol. 28,7 (2021): 704-712. doi: https://doi.org/10.1177/2047487319885041
Zaccardi F, Franks PW, Dudbridge F, Davies MJ, Khunti K, Yates T. Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: A UK Biobank study. Eur J Prev Cardiol. 2021 Jul 10;28(7):704-712. doi: 10.1177/2047487319885041. PMID: 34247229.
Copy Download .nbib Format: NLM
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.

Molecular psychiatry

van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA.
PMID: 26283641
Mol Psychiatry. 2016 Apr;21(4):585. doi: 10.1038/mp.2015.118. Epub 2015 Aug 18.

No abstract available.

Cite
van Erp TG, Hibar DP, Rasmussen JM, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2015;21(4):585doi: 10.1038/mp.2015.118.
van Erp, T. G., Hibar, D. P., Rasmussen, J. M., Glahn, D. C., Pearlson, G. D., Andreassen, O. A., Agartz, I., Westlye, L. T., Haukvik, U. K., Dale, A. M., Melle, I., Hartberg, C. B., Gruber, O., Kraemer, B., Zilles, D., Donohoe, G., Kelly, S., McDonald, C., Morris, D. W., Cannon, D. M., Corvin, A., Machielsen, M. W., Koenders, L., de Haan, L., Veltman, D. J., Satterthwaite, T. D., Wolf, D. H., Gur, R. C., Gur, R. E., Potkin, S. G., Mathalon, D. H., Mueller, B. A., Preda, A., Macciardi, F., Ehrlich, S., Walton, E., Hass, J., Calhoun, V. D., Bockholt, H. J., Sponheim, S. R., Shoemaker, J. M., van Haren, N. E., Pol, H. E., Ophoff, R. A., Kahn, R. S., Roiz-Santiañez, R., Crespo-Facorro, B., Wang, L., Alpert, K. I., Jönsson, E. G., Dimitrova, R., Bois, C., Whalley, H. C., McIntosh, A. M., Lawrie, S. M., Hashimoto, R., Thompson, P. M., & Turner, J. A. (2016). Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular psychiatry, 21(4), 585. https://doi.org/10.1038/mp.2015.118
van Erp, T G M, et al. "Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium." Molecular psychiatry vol. 21,4 (2016): 585. doi: https://doi.org/10.1038/mp.2015.118
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016 Apr;21(4):585. doi: 10.1038/mp.2015.118. Epub 2015 Aug 18. PMID: 26283641; PMCID: PMC5751698.
Copy Download .nbib Format: NLM
MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia.

Neurobiology of disease

Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, Maione S.
PMID: 34995755
Neurobiol Dis. 2022 Jan 04;164:105611. doi: 10.1016/j.nbd.2022.105611. Epub 2022 Jan 04.

Central post-stroke pain (CPSP) and associated depression remain poorly understood and pharmacological treatments are unsatisfactory. Recently, microglia activation was suggested to be involved in CPSP pathophysiology. The goal of this study was to investigate the effectiveness of a co-ultramicronized...

Cite
Infantino R, Schiano C, Luongo L, et al. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiol Dis. 2022;164:105611doi: 10.1016/j.nbd.2022.105611.
Infantino, R., Schiano, C., Luongo, L., Paino, S., Mansueto, G., Boccella, S., Guida, F., Ricciardi, F., Iannotta, M., Belardo, C., Marabese, I., Pieretti, G., Serra, N., Napoli, C., & Maione, S. (2022). MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiology of disease, 164105611. https://doi.org/10.1016/j.nbd.2022.105611
Infantino, Rosmara, et al. "MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia." Neurobiology of disease vol. 164 (2022): 105611. doi: https://doi.org/10.1016/j.nbd.2022.105611
Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, Maione S. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiol Dis. 2022 Jan 04;164:105611. doi: 10.1016/j.nbd.2022.105611. Epub 2022 Jan 04. PMID: 34995755.
Copy Download .nbib Format: NLM
Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity.

EClinicalMedicine

C L, H C, S R, I S, F Z, L DMB, K R, R L, K K.
PMID: 34308315
EClinicalMedicine. 2021 Jul 14;38:101008. doi: 10.1016/j.eclinm.2021.101008. eCollection 2021 Aug.

BACKGROUND: Reducing the high patient and economic burden of early readmissions after hospitalisation for heart failure (HF) has become a health policy priority of recent years.METHODS: An observational study linking Hospital Episode Statistics to socioeconomic and death data in...

Cite
C L, H C, S R, et al. Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity. EClinicalMedicine. 2021;38:101008doi: 10.1016/j.eclinm.2021.101008.
C, L., H, C., S, R., I, S., F, Z., L, D. M. B., K, R., R, L., & K, K. (2021). Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity. EClinicalMedicine, 38101008. https://doi.org/10.1016/j.eclinm.2021.101008
C, Lawson, et al. "Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity." EClinicalMedicine vol. 38 (2021): 101008. doi: https://doi.org/10.1016/j.eclinm.2021.101008
C L, H C, S R, I S, F Z, L DMB, K R, R L, K K. Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity. EClinicalMedicine. 2021 Jul 14;38:101008. doi: 10.1016/j.eclinm.2021.101008. eCollection 2021 Aug. PMID: 34308315; PMCID: PMC8283308.
Copy Download .nbib Format: NLM
MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia.

Neurobiology of disease

Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, Maione S.
PMID: 34995755
Neurobiol Dis. 2022 Jan 04;164:105611. doi: 10.1016/j.nbd.2022.105611. Epub 2022 Jan 04.

Central post-stroke pain (CPSP) and associated depression remain poorly understood and pharmacological treatments are unsatisfactory. Recently, microglia activation was suggested to be involved in CPSP pathophysiology. The goal of this study was to investigate the effectiveness of a co-ultramicronized...

Cite
Infantino R, Schiano C, Luongo L, et al. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiol Dis. 2022;164:105611doi: 10.1016/j.nbd.2022.105611.
Infantino, R., Schiano, C., Luongo, L., Paino, S., Mansueto, G., Boccella, S., Guida, F., Ricciardi, F., Iannotta, M., Belardo, C., Marabese, I., Pieretti, G., Serra, N., Napoli, C., & Maione, S. (2022). MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiology of disease, 164105611. https://doi.org/10.1016/j.nbd.2022.105611
Infantino, Rosmara, et al. "MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia." Neurobiology of disease vol. 164 (2022): 105611. doi: https://doi.org/10.1016/j.nbd.2022.105611
Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, Maione S. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiol Dis. 2022 Jan 04;164:105611. doi: 10.1016/j.nbd.2022.105611. Epub 2022 Jan 04. PMID: 34995755.
Copy Download .nbib Format: NLM
MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia.

Neurobiology of disease

Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, Maione S.
PMID: 34995755
Neurobiol Dis. 2022 Jan 04;164:105611. doi: 10.1016/j.nbd.2022.105611. Epub 2022 Jan 04.

Central post-stroke pain (CPSP) and associated depression remain poorly understood and pharmacological treatments are unsatisfactory. Recently, microglia activation was suggested to be involved in CPSP pathophysiology. The goal of this study was to investigate the effectiveness of a co-ultramicronized...

Cite
Infantino R, Schiano C, Luongo L, et al. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiol Dis. 2022;164:105611doi: 10.1016/j.nbd.2022.105611.
Infantino, R., Schiano, C., Luongo, L., Paino, S., Mansueto, G., Boccella, S., Guida, F., Ricciardi, F., Iannotta, M., Belardo, C., Marabese, I., Pieretti, G., Serra, N., Napoli, C., & Maione, S. (2022). MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiology of disease, 164105611. https://doi.org/10.1016/j.nbd.2022.105611
Infantino, Rosmara, et al. "MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia." Neurobiology of disease vol. 164 (2022): 105611. doi: https://doi.org/10.1016/j.nbd.2022.105611
Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, Maione S. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiol Dis. 2022 Jan 04;164:105611. doi: 10.1016/j.nbd.2022.105611. Epub 2022 Jan 04. PMID: 34995755.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 168 entries